The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

A combination of patient-reported outcome measures (PROMs) — including those evaluating general health, pain, quality of life, and disability scores — may serve as an effective tool for detecting ...

Long-term exposure to wildfire and nonwildfire fine particulate matter (PM2.5) is associated with increased odds of dementia diagnosis.

A scientific statement has been issued by the American Heart Association regarding the management and diagnosis of Kawasaki disease.

Vaccination of 27- to 45-year-olds against HPV is less cost-effective than vaccination of younger persons (aged 9 to 26 years).

COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.

Individuals born preterm have an increased risk for death from birth through their third and fourth decades of life.

Genicular artery embolization (GEA) is effective and safe for reducing osteoarthritis (OA) symptoms among patients with knee OA that is refractory to conservative therapy.

The presence of CVD may increase the risk of developing dementia among older patients with RA, though CVD was not found to mediate this relationship.

TAP block provided no clinically meaningful difference vs placebo in pain relief following minimally invasive abdominal surgery.

BRC-002 is an oral botanically-derived cannabinoid agent expected to reduce the pain and comorbidities associated with CRPS. The FDA has granted Orphan Drug designation to BRC-002 (cannabidiol ...